Life sciences investor ClavystBio and A*STAR have agreed to partner to co-develop and commercialise medtech innovations, while Singapore-listed Keppel Infrastructure Trust is selling a 24.62% stake in Australia’s Ventura Motors.
ClavystBio, A*STAR partner for medtech venture building in SG
ClavystBio, a Temasek-backed life sciences investor and venture builder, has signed an agreement with Singapore’s Agency for Science, Technology, and Research (A*STAR) to co-develop and commercialise medtech innovations in the city-state.
The partnership aims to build and scale medical technology ventures by combining ClavystBio’s investment and venture-building expertise with A*STAR’s research capabilities, per the announcement.
The initiative will tap national programmes such as MedTech Catapult and Diagnostics Development Hub (DxD Hub) to support product development and market readiness.
ClavystBio will provide capital, business guidance, and industry networks, while A*STAR will contribute technical expertise and incubate ventures.
Over this two-year partnership, the parties will work towards the co-creation of new medtech ventures, investments into A*STAR-affiliated companies, and foster collaborations between A*STAR and ClavystBio’s portfolio companies.
Keppel partially exits Australia’s Ventura Motors
Singapore-listed Keppel Infrastructure Trust (KIT) is selling a 24.62% stake in Ventura Motors, the largest public bus operator in the Australian state of Victoria, for A$130 million (about $84.9 million).
Headquartered in Melbourne, Ventura operates approximately 530 of the city’s 1,200 public bus routes, moving more than 42 million passengers annually. The company owns around 900 buses and manages 12 depots across the state of Victoria.
Ventura also operates Victoria’s first fully electric bus depot and manages the state’s largest fleet of zero-emission electric buses under a government trial.
Following the deal, KIT will retain a 73.06% interest in Ventura, while Ventura CEO Andrew Cornwall will continue to hold 2.32%, according to an announcement by KIT’s trustee-manager, Keppel Infrastructure Fund Management.
The transaction is subject to regulatory approvals and is expected to close in the third quarter of 2025
The sale is part of KIT’s capital recycling strategy and follows its earlier divestment of a 50% stake in Philippine Coastal Storage & Pipeline Corporation. Combined, the two deals are expected to generate proceeds of approximately S$301 million.
